Agilon Health, Inc.
AGL Healthcare Medical Care Facilities
Agilon Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.9 billion, down 2.11% from fiscal 2024. In the quarter to June 2026, revenue grew 7.15%, EPS grew 117.1%, free cash flow fell 50.2% and total debt fell 13.3%, each against the same quarter a year earlier. Dividend growth for five consecutive years; insiders bought in the last twelve months.
Follow AGL
Agilon Health, Inc. (AGL) Piotroski F-score
Agilon Health, Inc.'s Piotroski F-score for fiscal 2025 is 3 out of 9: 3 of nine tests of profitability, leverage and efficiency passed, unchanged from fiscal 2024.
Piotroski F-score, annual
Embed this chart
Annual newest first
| Period | Piotroski F-score | Change (points) |
|---|---|---|
| FY2025 | 3 | 0.00 |
| FY2024 | 3 | 0.00 |
| FY2023 | 3 | 0.00 |
| FY2022 | 3 | 0.00 |
| FY2021 | 3 | (2.00) |
| FY2020 | 5 | — |
How fiscal 2025’s score is made up
| Test | This year | Year before | Result | Points |
|---|---|---|---|---|
| Positive return on assets | (26.04%) | (14.97%) | Fail | 0 |
| Positive operating cash flow | (105.76m) | (57.78m) | Fail | 0 |
| Rising return on assets | (26.04%) | (14.97%) | Fail | 0 |
| Cash flow above net income | 285.58m | 202.37m | Pass | 1 |
| Falling long-term leverage | 0.01 | 0.02 | Pass | 1 |
| Rising current ratio | 1.02 | 1.27 | Fail | 0 |
| No new shares issued | 16,558,800 | 16,438,600 | Fail | 0 |
| Rising gross margin | (2.70%) | 0.08% | Fail | 0 |
| Rising asset turnover | 3.95 | 3.49 | Pass | 1 |
| Piotroski F-score | Weak — most fundamentals deteriorated | 3 | ||
How the Piotroski F-score works
One point for each of nine tests, this fiscal year against the one before: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, a rising current ratio, no new shares issued, a rising gross margin and rising asset turnover. The ratios are the ones on this site, so each can be checked.
Joseph Piotroski (2000) called 8–9 high and 0–1 low; reading it in three bands is the common convention:
| 7–9 | Strong — most fundamentals improved |
|---|---|
| 4–6 | Mixed |
| 0–3 | Weak — most fundamentals deteriorated |
Where this differs from the paper: return on assets is on average rather than beginning-of-year assets, and weighted basic shares stand in for shares issued. The score is shown only when all nine tests can be worked out, which takes three fiscal years; banks and insurers, which report no current assets or gross profit, have none.
Piotroski F-score against peers
| Company | Piotroski F-score |
|---|---|
| HCSG Healthcare Services Group, Inc. compare | 8 |
| NUTX Nutex Health Inc. compare | 7 |
| USPH U.S. Physical Therapy, Inc. compare | 7 |
| ARDT Ardent Health, Inc. compare | 6 |
| AMN AMN Healthcare Services Inc compare | 5 |
| PNTG The Pennant Group, Inc. compare | 5 |
| SNDA Sonida Senior Living, Inc. compare | 4 |
| AGL Agilon Health, Inc. | 3 |
| CMPS COMPASS Pathways PLC Sponsored ADR compare | — |
What Piotroski F-score is
The Piotroski F-Score tells an investor how many signs of improving profitability, funding and efficiency a company shows against a year earlier.
One point for each of nine tests against a year earlier: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, rising current ratio, no new shares issued, rising gross margin, and rising asset turnover